Oculis Holding AG
Status: Publicly traded
Direct answer
Oculis Holding AG is publicly traded on NASDAQ under the ticker OCS.
Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medications for various ocular conditions, addressing both the anterior and posterior segments of the eye. A key asset in its therapeutic portfolio is OCS-01, a topical formulation of dexamethasone, currently progressing through Phase 3 clinical trials for the management of diabetic...
Can you invest in Oculis Holding AG?
Yes. Oculis Holding AG is publicly traded on NASDAQ under the ticker OCS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Oculis Holding AG
Detailed equity research is provided by MarketSnap.